Top Markets
Coin of the day
Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC
Rank in Stocks #1197
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Share Price
$72.44
Last synced: 2026-08-24
Market Cap
$20.13B
Change (1 day)
1.25%
Change (1 year)
17.60%
Country
DK
Trade Novonesis (Novozymes) B (NSISBC)
Operating Margin for Novonesis (Novozymes) B (NSISBC)
Operating Margin as of 2026 TTM: 0.00%
According to Novonesis (Novozymes) B latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Novonesis (Novozymes) B from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
28.66% -
GB
0.00% -
FR
16.36% -
US
17.37% -
US
-4.71% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.